Literature DB >> 10332003

Recurrent infections in homozygous sickle cell disease.

S A Magnus1, I R Hambleton, F Moosdeen, G R Serjeant.   

Abstract

The characteristics of 214 episodes of invasive bacterial infection among 176 patients with homozygous sickle cell (SS) disease were examined. Streptococcus pneumoniae occurred in 81 episodes, Salmonella spp in 70, Haemophilus influenzae type b in 30, Escherichia coli in 24, and Klebsiella spp in nine. The cumulative incidence showed that S pneumoniae and H influenzae occurred predominantly before 5 years of age and were uncommon thereafter, Salmonella spp increased almost linearly with age, and Klebsiella spp and E coli predominated in patients over 10 years of age. Escherichia coli had a different epidemiology-it was found in older children, almost entirely girls. Excluding this organism from an analysis of recurrent bacterial infections, the standardised incidence rates for second and third infections were 4.8 and 15.8 times greater, respectively, than the SS population average. This implies that the susceptibility to infection is characteristic of a subgroup of patients with SS disease and that sick patients with previous bacteraemia should be investigated early and aggressively for further infection.

Entities:  

Mesh:

Year:  1999        PMID: 10332003      PMCID: PMC1717938          DOI: 10.1136/adc.80.6.537

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  10 in total

1.  Bacterial meningitis and septicemia in sickle cell disease.

Authors:  G D Overturf; D Powars; L J Baraff
Journal:  Am J Dis Child       Date:  1977-07

2.  Early splenomegaly in homozygous sickle-cell disease: An indicator of susceptibility to infection.

Authors:  D W Rogers; S Vaidya; G R Serjeant
Journal:  Lancet       Date:  1978-11-04       Impact factor: 79.321

3.  Developmental aspects of splenic function in sickle cell diseases.

Authors:  H A Pearson; S McIntosh; A K Ritchey; J S Lobel; Y Rooks; D Johnston
Journal:  Blood       Date:  1979-03       Impact factor: 22.113

4.  Splenic function in sickle cell disease in the Eastern Province of Saudi Arabia.

Authors:  B Al-Awamy; W A Wilson; H A Pearson
Journal:  J Pediatr       Date:  1984-05       Impact factor: 4.406

Review 5.  Bacterial infection and sickle cell anemia. An analysis of 250 infections in 166 patients and a review of the literature.

Authors:  E Barrett-Connor
Journal:  Medicine (Baltimore)       Date:  1971-03       Impact factor: 1.889

6.  Septicemia caused by Salmonella infection: an overlooked complication of sickle cell disease.

Authors:  J Wright; P Thomas; G R Serjeant
Journal:  J Pediatr       Date:  1997-03       Impact factor: 4.406

7.  Bacteremia in sickle hemoglobinopathies.

Authors:  H S Zarkowsky; D Gallagher; F M Gill; W C Wang; J M Falletta; W M Lande; P S Levy; J I Verter; D Wethers
Journal:  J Pediatr       Date:  1986-10       Impact factor: 4.406

8.  Splenic function in Saudi children with sickle cell disease.

Authors:  A Mallouh; G M Burke; M Salamah; M S Ahmad
Journal:  Ann Trop Paediatr       Date:  1984-06

9.  Clinicopathologic characteristics of septicemia in sickle cell disease.

Authors:  J S Lobel; K E Bove
Journal:  Am J Dis Child       Date:  1982-06

10.  Is there an increased risk of Haemophilus influenzae septicemia in children with sickle cell anemia?

Authors:  D Powars; G Overturf; E Turner
Journal:  Pediatrics       Date:  1983-06       Impact factor: 7.124

  10 in total
  16 in total

Review 1.  Taming the elephant: Salmonella biology, pathogenesis, and prevention.

Authors:  Helene L Andrews-Polymenis; Andreas J Bäumler; Beth A McCormick; Ferric C Fang
Journal:  Infect Immun       Date:  2010-04-12       Impact factor: 3.441

Review 2.  Iron and immunity: immunological consequences of iron deficiency and overload.

Authors:  Bobby J Cherayil
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2010-09-28       Impact factor: 4.291

Review 3.  Prevention and management of infection in children with sickle cell anaemia.

Authors:  W Y Wong
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 4.  Ironing out the wrinkles in host defense: interactions between iron homeostasis and innate immunity.

Authors:  Lijian Wang; Bobby J Cherayil
Journal:  J Innate Immun       Date:  2009-03-23       Impact factor: 7.349

5.  Iron chelators modulate the fusogenic properties of Salmonella-containing phagosomes.

Authors:  Nada Jabado; Patricia Cuellar-Mata; Sergio Grinstein; Philippe Gros
Journal:  Proc Natl Acad Sci U S A       Date:  2003-04-23       Impact factor: 11.205

6.  The increasing prevalence of childhood sickle-cell disease in Ireland.

Authors:  C McMahon; C O Callaghan; D O'Brien; O P Smith
Journal:  Ir J Med Sci       Date:  2001 Jul-Sep       Impact factor: 1.568

7.  Bacteraemia in homozygous sickle cell disease in Africa: is pneumococcal prophylaxis justified?

Authors:  M E Kizito; E Mworozi; C Ndugwa; G R Serjeant
Journal:  Arch Dis Child       Date:  2006-03-10       Impact factor: 3.791

8.  Attenuated inflammatory responses in hemochromatosis reveal a role for iron in the regulation of macrophage cytokine translation.

Authors:  Lijian Wang; Erin E Johnson; Hai Ning Shi; W Allan Walker; Marianne Wessling-Resnick; Bobby J Cherayil
Journal:  J Immunol       Date:  2008-08-15       Impact factor: 5.422

9.  Selective modulation of TLR4-activated inflammatory responses by altered iron homeostasis in mice.

Authors:  Lijian Wang; Lynne Harrington; Estela Trebicka; Hai Ning Shi; Jonathan C Kagan; Charles C Hong; Herbert Y Lin; Jodie L Babitt; Bobby J Cherayil
Journal:  J Clin Invest       Date:  2009-10-05       Impact factor: 14.808

10.  Both hemolytic anemia and malaria parasite-specific factors increase susceptibility to Nontyphoidal Salmonella enterica serovar typhimurium infection in mice.

Authors:  Christelle M Roux; Brian P Butler; Jennifer Y Chau; Tatiane A Paixao; Kong Wai Cheung; Renato L Santos; Shirley Luckhart; Renée M Tsolis
Journal:  Infect Immun       Date:  2010-01-25       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.